NTCM
CLBT icon

Nine Ten Capital Management’s Cellebrite CLBT Stock Holding History

Nine Ten Capital Management’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.3M Buy
4,126,808
+682,933
+20% +$9.03M 18.75% 3
2026
Q1 		$47.5M Buy
3,443,875
+964,148
+39% +$14.5M 15.07% 2
2025
Q4 		$44.7M Hold
2,479,727
– – 14.16% 3
2025
Q3 		$45.9M Buy
2,479,727
+358,193
+17% +$5.63M 11.84% 4
2025
Q2 		$33.9M Buy
2,121,534
+122,500
+6% +$2.18M 10.1% 5
2025
Q1 		$38.8M Sell
1,999,034
-1,606,570
-45% -$33.8M 14.5% 3
2024
Q4 		$79.4M Sell
3,605,604
-721,194
-17% -$13.9M 22.67% 1
2024
Q3 		$72.9M Buy
4,326,798
+403,086
+10% +$5.98M 22.02% 1
2024
Q2 		$46.9M Buy
3,923,712
+452,514
+13% +$5.06M 18.05% 1
2024
Q1 		$38.5M Sell
3,471,198
-235,000
-6% -$2.4M 11.71% 4
2023
Q4 		$32.1M Buy
3,706,198
+2,639,596
+247% +$20.5M 8.07% 6
2023
Q3 		$8.16M Buy
1,066,602
+651,634
+157% +$4.89M 2.49% 10
2023
Q2 		$2.99M Buy
+414,968
New +$2.42M 1% 8

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Nine Ten Capital Management's CLBT Position: Q2 2026 in Review

Nine Ten Capital Management increased its Cellebrite (CLBT) stake by 20% in Q2 2026, buying an estimated $9.03M and bringing the position to 4,126,808 shares worth $60.3M. The position accounts for 18.75% of the portfolio, ranked #3.

Nine Ten Capital Management first reported a position in CLBT in Q2 2023 and has held it in 13 quarters since. The position peaked at $79.4M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Nine Ten Capital Management held 4,126,808 shares of Cellebrite worth $60.3M as of Q2 2026.
  • Nine Ten Capital Management bought 682,933 Cellebrite shares in Q2 2026, an estimated $9.03M.
  • Cellebrite made up 18.75% of Nine Ten Capital Management's portfolio in Q2 2026, its #3 holding.
  • Nine Ten Capital Management first reported a position in Cellebrite in Q2 2023 and has held it in 13 quarters since.
  • Nine Ten Capital Management's Cellebrite position peaked at $79.4M in Q4 2024.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Nine Ten Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.